Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15102658

Clin. Cancer Res. 2004 Apr 15 10 8 2584-6

Download in:

View as

Triples

General Info

PMID
15102658